Table of Content

1 Interventional Oncology Device Market Overview
1.1 Product Overview and Scope of Interventional Oncology Device
1.2 Interventional Oncology Device Segment by Type
1.2.1 Global Interventional Oncology Device Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Ablation Devices
1.2.3 Embolization Devices
1.2.4 Supporting Devices
1.2.5 Next Generation Devices
1.3 Interventional Oncology Device Segment by Application
1.3.1 Interventional Oncology Device Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Specialty Clinics and Ambulatory Surgical Centers
1.3.4 Others (Homecare and Research Institutes)
1.4 Global Interventional Oncology Device Market Size Estimates and Forecasts
1.4.1 Global Interventional Oncology Device Revenue 2016-2027
1.4.2 Global Interventional Oncology Device Sales 2016-2027
1.4.3 Interventional Oncology Device Market Size by Region: 2016 Versus 2021 Versus 2027

2 Interventional Oncology Device Market Competition by Manufacturers
2.1 Global Interventional Oncology Device Sales Market Share by Manufacturers (2016-2021)
2.2 Global Interventional Oncology Device Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Interventional Oncology Device Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Interventional Oncology Device Manufacturing Sites, Area Served, Product Type
2.5 Interventional Oncology Device Market Competitive Situation and Trends
2.5.1 Interventional Oncology Device Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Interventional Oncology Device Players Market Share by Revenue
2.5.3 Global Interventional Oncology Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Interventional Oncology Device Retrospective Market Scenario by Region
3.1 Global Interventional Oncology Device Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Interventional Oncology Device Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Interventional Oncology Device Market Facts & Figures by Country
3.3.1 North America Interventional Oncology Device Sales by Country
3.3.2 North America Interventional Oncology Device Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Interventional Oncology Device Market Facts & Figures by Country
3.4.1 Europe Interventional Oncology Device Sales by Country
3.4.2 Europe Interventional Oncology Device Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Interventional Oncology Device Market Facts & Figures by Region
3.5.1 Asia Pacific Interventional Oncology Device Sales by Region
3.5.2 Asia Pacific Interventional Oncology Device Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Interventional Oncology Device Market Facts & Figures by Country
3.6.1 Latin America Interventional Oncology Device Sales by Country
3.6.2 Latin America Interventional Oncology Device Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Interventional Oncology Device Market Facts & Figures by Country
3.7.1 Middle East and Africa Interventional Oncology Device Sales by Country
3.7.2 Middle East and Africa Interventional Oncology Device Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Interventional Oncology Device Historic Market Analysis by Type
4.1 Global Interventional Oncology Device Sales Market Share by Type (2016-2021)
4.2 Global Interventional Oncology Device Revenue Market Share by Type (2016-2021)
4.3 Global Interventional Oncology Device Price by Type (2016-2021)

5 Global Interventional Oncology Device Historic Market Analysis by Application
5.1 Global Interventional Oncology Device Sales Market Share by Application (2016-2021)
5.2 Global Interventional Oncology Device Revenue Market Share by Application (2016-2021)
5.3 Global Interventional Oncology Device Price by Application (2016-2021)

6 Key Companies Profiled
6.1 AngioDynamics, Inc.
6.1.1 AngioDynamics, Inc. Corporation Information
6.1.2 AngioDynamics, Inc. Description and Business Overview
6.1.3 AngioDynamics, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AngioDynamics, Inc. Product Portfolio
6.1.5 AngioDynamics, Inc. Recent Developments/Updates
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Description and Business Overview
6.2.3 BD Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
6.2.4 BD Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Boston Scientific Corporation
6.3.1 Boston Scientific Corporation Corporation Information
6.3.2 Boston Scientific Corporation Description and Business Overview
6.3.3 Boston Scientific Corporation Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Boston Scientific Corporation Product Portfolio
6.3.5 Boston Scientific Corporation Recent Developments/Updates
6.4 BTG Plc
6.4.1 BTG Plc Corporation Information
6.4.2 BTG Plc Description and Business Overview
6.4.3 BTG Plc Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
6.4.4 BTG Plc Product Portfolio
6.4.5 BTG Plc Recent Developments/Updates
6.5 Eckert & Ziegler BEBIG
6.5.1 Eckert & Ziegler BEBIG Corporation Information
6.5.2 Eckert & Ziegler BEBIG Description and Business Overview
6.5.3 Eckert & Ziegler BEBIG Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Eckert & Ziegler BEBIG Product Portfolio
6.5.5 Eckert & Ziegler BEBIG Recent Developments/Updates
6.6 HealthTronics, Inc.
6.6.1 HealthTronics, Inc. Corporation Information
6.6.2 HealthTronics, Inc. Description and Business Overview
6.6.3 HealthTronics, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
6.6.4 HealthTronics, Inc. Product Portfolio
6.6.5 HealthTronics, Inc. Recent Developments/Updates
6.7 IceCure Medical
6.6.1 IceCure Medical Corporation Information
6.6.2 IceCure Medical Description and Business Overview
6.6.3 IceCure Medical Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
6.4.4 IceCure Medical Product Portfolio
6.7.5 IceCure Medical Recent Developments/Updates
6.8 Medtronic PLC
6.8.1 Medtronic PLC Corporation Information
6.8.2 Medtronic PLC Description and Business Overview
6.8.3 Medtronic PLC Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Medtronic PLC Product Portfolio
6.8.5 Medtronic PLC Recent Developments/Updates
6.9 Medwaves, Inc.
6.9.1 Medwaves, Inc. Corporation Information
6.9.2 Medwaves, Inc. Description and Business Overview
6.9.3 Medwaves, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Medwaves, Inc. Product Portfolio
6.9.5 Medwaves, Inc. Recent Developments/Updates
6.10 Merit Medical Systems, Inc.
6.10.1 Merit Medical Systems, Inc. Corporation Information
6.10.2 Merit Medical Systems, Inc. Description and Business Overview
6.10.3 Merit Medical Systems, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Merit Medical Systems, Inc. Product Portfolio
6.10.5 Merit Medical Systems, Inc. Recent Developments/Updates
6.11 Sanarus Technologies, Inc.
6.11.1 Sanarus Technologies, Inc. Corporation Information
6.11.2 Sanarus Technologies, Inc. Interventional Oncology Device Description and Business Overview
6.11.3 Sanarus Technologies, Inc. Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Sanarus Technologies, Inc. Product Portfolio
6.11.5 Sanarus Technologies, Inc. Recent Developments/Updates
6.12 Sirtex Medical Ltd.
6.12.1 Sirtex Medical Ltd. Corporation Information
6.12.2 Sirtex Medical Ltd. Interventional Oncology Device Description and Business Overview
6.12.3 Sirtex Medical Ltd. Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Sirtex Medical Ltd. Product Portfolio
6.12.5 Sirtex Medical Ltd. Recent Developments/Updates
6.13 Sonacare Medical
6.13.1 Sonacare Medical Corporation Information
6.13.2 Sonacare Medical Interventional Oncology Device Description and Business Overview
6.13.3 Sonacare Medical Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Sonacare Medical Product Portfolio
6.13.5 Sonacare Medical Recent Developments/Updates
6.14 Terumo Corporation
6.14.1 Terumo Corporation Corporation Information
6.14.2 Terumo Corporation Interventional Oncology Device Description and Business Overview
6.14.3 Terumo Corporation Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Terumo Corporation Product Portfolio
6.14.5 Terumo Corporation Recent Developments/Updates
6.15 Trod Medical
6.15.1 Trod Medical Corporation Information
6.15.2 Trod Medical Interventional Oncology Device Description and Business Overview
6.15.3 Trod Medical Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Trod Medical Product Portfolio
6.15.5 Trod Medical Recent Developments/Updates
6.16 Cook Meidical LLC
6.16.1 Cook Meidical LLC Corporation Information
6.16.2 Cook Meidical LLC Interventional Oncology Device Description and Business Overview
6.16.3 Cook Meidical LLC Interventional Oncology Device Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Cook Meidical LLC Product Portfolio
6.16.5 Cook Meidical LLC Recent Developments/Updates

7 Interventional Oncology Device Manufacturing Cost Analysis
7.1 Interventional Oncology Device Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Interventional Oncology Device
7.4 Interventional Oncology Device Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Interventional Oncology Device Distributors List
8.3 Interventional Oncology Device Customers

9 Interventional Oncology Device Market Dynamics
9.1 Interventional Oncology Device Industry Trends
9.2 Interventional Oncology Device Growth Drivers
9.3 Interventional Oncology Device Market Challenges
9.4 Interventional Oncology Device Market Restraints

10 Global Market Forecast
10.1 Interventional Oncology Device Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Interventional Oncology Device by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Interventional Oncology Device by Type (2022-2027)
10.2 Interventional Oncology Device Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Interventional Oncology Device by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Interventional Oncology Device by Application (2022-2027)
10.3 Interventional Oncology Device Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Interventional Oncology Device by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Interventional Oncology Device by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Interventional Oncology Device Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Interventional Oncology Device Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Interventional Oncology Device Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Interventional Oncology Device Covered in This Study
Table 5. Global Interventional Oncology Device Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Interventional Oncology Device Sales Share by Manufacturers (2016-2021)
Table 7. Global Interventional Oncology Device Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Interventional Oncology Device Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Interventional Oncology Device Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Interventional Oncology Device Manufacturing Sites and Area Served
Table 11. Manufacturers Interventional Oncology Device Product Type
Table 12. Global Interventional Oncology Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Interventional Oncology Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interventional Oncology Device as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Interventional Oncology Device Sales by Region (2016-2021) & (K Units)
Table 16. Global Interventional Oncology Device Sales Market Share by Region (2016-2021)
Table 17. Global Interventional Oncology Device Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Interventional Oncology Device Sales by Country (2016-2021) & (K Units)
Table 19. North America Interventional Oncology Device Sales Market Share by Country (2016-2021)
Table 20. North America Interventional Oncology Device Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Interventional Oncology Device Revenue Market Share by Country (2016-2021)
Table 22. Europe Interventional Oncology Device Sales by Country (2016-2021) & (K Units)
Table 23. Europe Interventional Oncology Device Sales Market Share by Country (2016-2021)
Table 24. Europe Interventional Oncology Device Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Interventional Oncology Device Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Interventional Oncology Device Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Interventional Oncology Device Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Interventional Oncology Device Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Interventional Oncology Device Revenue Market Share by Region (2016-2021)
Table 30. Latin America Interventional Oncology Device Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Interventional Oncology Device Sales Market Share by Country (2016-2021)
Table 32. Latin America Interventional Oncology Device Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Interventional Oncology Device Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Interventional Oncology Device Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Interventional Oncology Device Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Interventional Oncology Device Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Interventional Oncology Device Revenue Market Share by Country (2016-2021)
Table 38. Global Interventional Oncology Device Sales (K Units) by Type (2016-2021)
Table 39. Global Interventional Oncology Device Sales Market Share by Type (2016-2021)
Table 40. Global Interventional Oncology Device Revenue (Million US$) by Type (2016-2021)
Table 41. Global Interventional Oncology Device Revenue Share by Type (2016-2021)
Table 42. Global Interventional Oncology Device Price (US$/Unit) by Type (2016-2021)
Table 43. Global Interventional Oncology Device Sales (K Units) by Application (2016-2021)
Table 44. Global Interventional Oncology Device Sales Market Share by Application (2016-2021)
Table 45. Global Interventional Oncology Device Revenue (Million US$) by Application (2016-2021)
Table 46. Global Interventional Oncology Device Revenue Share by Application (2016-2021)
Table 47. Global Interventional Oncology Device Price (US$/Unit) by Application (2016-2021)
Table 48. AngioDynamics, Inc. Corporation Information
Table 49. AngioDynamics, Inc. Description and Business Overview
Table 50. AngioDynamics, Inc. Interventional Oncology Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. AngioDynamics, Inc. Interventional Oncology Device Product
Table 52. AngioDynamics, Inc. Recent Developments/Updates
Table 53. BD Corporation Information
Table 54. BD Description and Business Overview
Table 55. BD Interventional Oncology Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. BD Interventional Oncology Device Product
Table 57. BD Recent Developments/Updates
Table 58. Boston Scientific Corporation Corporation Information
Table 59. Boston Scientific Corporation Description and Business Overview
Table 60. Boston Scientific Corporation Interventional Oncology Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Boston Scientific Corporation Interventional Oncology Device Product
Table 62. Boston Scientific Corporation Recent Developments/Updates
Table 63. BTG Plc Corporation Information
Table 64. BTG Plc Description and Business Overview
Table 65. BTG Plc Interventional Oncology Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. BTG Plc Interventional Oncology Device Product
Table 67. BTG Plc Recent Developments/Updates
Table 68. Eckert & Ziegler BEBIG Corporation Information
Table 69. Eckert & Ziegler BEBIG Description and Business Overview
Table 70. Eckert & Ziegler BEBIG Interventional Oncology Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Eckert & Ziegler BEBIG Interventional Oncology Device Product
Table 72. Eckert & Ziegler BEBIG Recent Developments/Updates
Table 73. HealthTronics, Inc. Corporation Information
Table 74. HealthTronics, Inc. Description and Business Overview
Table 75. HealthTronics, Inc. Interventional Oncology Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. HealthTronics, Inc. Interventional Oncology Device Product
Table 77. HealthTronics, Inc. Recent Developments/Updates
Table 78. IceCure Medical Corporation Information
Table 79. IceCure Medical Description and Business Overview
Table 80. IceCure Medical Interventional Oncology Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. IceCure Medical Interventional Oncology Device Product
Table 82. IceCure Medical Recent Developments/Updates
Table 83. Medtronic PLC Corporation Information
Table 84. Medtronic PLC Description and Business Overview
Table 85. Medtronic PLC Interventional Oncology Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Medtronic PLC Interventional Oncology Device Product
Table 87. Medtronic PLC Recent Developments/Updates
Table 88. Medwaves, Inc. Corporation Information
Table 89. Medwaves, Inc. Description and Business Overview
Table 90. Medwaves, Inc. Interventional Oncology Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Medwaves, Inc. Interventional Oncology Device Product
Table 92. Medwaves, Inc. Recent Developments/Updates
Table 93. Merit Medical Systems, Inc. Corporation Information
Table 94. Merit Medical Systems, Inc. Description and Business Overview
Table 95. Merit Medical Systems, Inc. Interventional Oncology Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Merit Medical Systems, Inc. Interventional Oncology Device Product
Table 97. Merit Medical Systems, Inc. Recent Developments/Updates
Table 98. Sanarus Technologies, Inc. Corporation Information
Table 99. Sanarus Technologies, Inc. Description and Business Overview
Table 100. Sanarus Technologies, Inc. Interventional Oncology Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Sanarus Technologies, Inc. Interventional Oncology Device Product
Table 102. Sanarus Technologies, Inc. Recent Developments/Updates
Table 103. Sirtex Medical Ltd. Corporation Information
Table 104. Sirtex Medical Ltd. Description and Business Overview
Table 105. Sirtex Medical Ltd. Interventional Oncology Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Sirtex Medical Ltd. Interventional Oncology Device Product
Table 107. Sirtex Medical Ltd. Recent Developments/Updates
Table 108. Sonacare Medical Corporation Information
Table 109. Sonacare Medical Description and Business Overview
Table 110. Sonacare Medical Interventional Oncology Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Sonacare Medical Interventional Oncology Device Product
Table 112. Sonacare Medical Recent Developments/Updates
Table 113. Terumo Corporation Corporation Information
Table 114. Terumo Corporation Description and Business Overview
Table 115. Terumo Corporation Interventional Oncology Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Terumo Corporation Interventional Oncology Device Product
Table 117. Terumo Corporation Recent Developments/Updates
Table 118. Trod Medical Corporation Information
Table 119. Trod Medical Description and Business Overview
Table 120. Trod Medical Interventional Oncology Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Trod Medical Interventional Oncology Device Product
Table 122. Trod Medical Recent Developments/Updates
Table 123. Cook Meidical LLC Corporation Information
Table 124. Cook Meidical LLC Description and Business Overview
Table 125. Cook Meidical LLC Interventional Oncology Device Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Cook Meidical LLC Interventional Oncology Device Product
Table 127. Cook Meidical LLC Recent Developments/Updates
Table 128. Production Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Interventional Oncology Device Distributors List
Table 131. Interventional Oncology Device Customers List
Table 132. Interventional Oncology Device Market Trends
Table 133. Interventional Oncology Device Growth Drivers
Table 134. Interventional Oncology Device Market Restraints
Table 135. Global Interventional Oncology Device Sales Forecast by Type (2022-2027) & (K Units)
Table 136. Global Interventional Oncology Device Sales Market Share Forecast by Type (2022-2027)
Table 137. Global Interventional Oncology Device Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 138. Global Interventional Oncology Device Revenue Market Share Forecast by Type (2022-2027)
Table 139. Global Interventional Oncology Device Sales Forecast by Application (2022-2027) & (K Units)
Table 140. Global Interventional Oncology Device Sales Market Share Forecast by Application (2022-2027)
Table 141. Global Interventional Oncology Device Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 142. Global Interventional Oncology Device Revenue Market Share Forecast by Application (2022-2027)
Table 143. Global Interventional Oncology Device Sales Forecast by Region (2022-2027) & (K Units)
Table 144. Global Interventional Oncology Device Sales Market Share Forecast by Region (2022-2027)
Table 145. Global Interventional Oncology Device Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 146. Global Interventional Oncology Device Revenue Market Share Forecast by Region (2022-2027)
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Interventional Oncology Device
Figure 2. Global Interventional Oncology Device Market Share by Type in 2020 & 2027
Figure 3. Ablation Devices Product Picture
Figure 4. Embolization Devices Product Picture
Figure 5. Supporting Devices Product Picture
Figure 6. Next Generation Devices Product Picture
Figure 7. Global Interventional Oncology Device Market Share by Application in 2020 & 2027
Figure 8. Hospitals
Figure 9. Specialty Clinics and Ambulatory Surgical Centers
Figure 10. Others (Homecare and Research Institutes)
Figure 11. Global Interventional Oncology Device Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Interventional Oncology Device Market Size 2016-2027 (US$ Million)
Figure 13. Global Interventional Oncology Device Sales 2016-2027 (K Units)
Figure 14. Global Interventional Oncology Device Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Interventional Oncology Device Sales Share by Manufacturers in 2020
Figure 16. Global Interventional Oncology Device Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Interventional Oncology Device Players: Market Share by Revenue in 2020
Figure 18. Interventional Oncology Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Interventional Oncology Device Sales Market Share by Region (2016-2021)
Figure 20. Global Interventional Oncology Device Sales Market Share by Region in 2020
Figure 21. Global Interventional Oncology Device Revenue Market Share by Region (2016-2021)
Figure 22. Global Interventional Oncology Device Revenue Market Share by Region in 2020
Figure 23. U.S. Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Interventional Oncology Device Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Interventional Oncology Device by Type (2016-2021)
Figure 48. Sales Market Share of Interventional Oncology Device by Application (2016-2021)
Figure 49. Sales Market Share of Interventional Oncology Device by Application in 2020
Figure 50. Revenue Share of Interventional Oncology Device by Application (2016-2021)
Figure 51. Revenue Share of Interventional Oncology Device by Application in 2020
Figure 52. Manufacturing Cost Structure of Interventional Oncology Device
Figure 53. Manufacturing Process Analysis of Interventional Oncology Device
Figure 54. Interventional Oncology Device Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed